- Release Date: 07/06/13 10:30
- Summary: RIGHT: EBO: Renounceable Entitlements (Rights - EBORC)
- Price Sensitive: No
- Download Document 1.68KB
EBO 07/06/2013 08:30 RIGHT REL: 0830 HRS Ebos Group Limited RIGHT: EBO: Renounceable Entitlements (Rights - EBORC) Quotation Notice Renounceable Entitlements (Rights) (EBORC) Company Name: EBOS Group Limited Prospectus Dated: 5 June 2013 Details of Offer: A pro-rata renounceable Entitlement Offer of 7 new ordinary shares for every 20 existing ordinary shares held on the Record Date. The Offer will only proceed if the Symbion Transaction is approved by EBOS shareholders at the Special Meeting on 14 June 2013. Ratio (New: Existing): 7 : 20 Issue Price: $6.50 per share Issue Price Payable: In full on application Ex Entitlements and Entitlements Commence Trading: Wednesday, 12 June 2013* Record Date: 5pm, Friday, 14 June 2013 Entitlement Offer Opens Monday, 17 June 2013 Prospectus and Letters of Entitlement Sent to Shareholders: By Monday, 17 June 2013 Entitlement Quotation Ceases: Tuesday, 25 June 2013 Entitlement Offer Closes: 5pm, Monday, 1 July 2013 Allotment of New Shares: Friday, 5 July 2013 Commencement of Trading of New Shares: Friday, 5 July 2013 Share Registry: Computershare Investor Services (RMLT) Mailing of securities transactions statements: By Friday, 12 July 2013 Settlement Status: NZCDC settlement system Tradeable Entitlements Code: EBORC ISIN: NZEBOE0004S0 T.Bennett, Chief Executive Officer, NZX Limited 07 June 2013 The Entitlements will be quoted and tradeable on a conditional settlement basis until EBO has advised NZX of the results of the Special Meeting on 14 June 2013. Trading of the Entitlements on a normal settlement basis is expected to commence on 17 June 2013. End CA:00237146 For:EBO Type:RIGHT Time:2013-06-07 08:30:11
- Forums
- NZX - By Stock
- EBO
- Ann: RIGHT: EBO: Renounceable Entitlements (Right
Ann: RIGHT: EBO: Renounceable Entitlements (Right
Featured News
Add EBO (NZSX) to my watchlist
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online